Oxurion NV (EBR:OXUR)
Belgium · Delayed Price · Currency is EUR 0.0246
0.00 (0.00%)
Aug 15, 2025, 5:21 PM CET
Oxurion NV Market Cap
Oxurion NV has a market cap or net worth of €1.24 million as of August 15, 2025. Its market cap has decreased by -7.26% in one year.
Market Cap
1.24M
Enterprise Value
12.11M
Revenue
3.00K
Ranking
n/a
PE Ratio
0.26
Stock Price
€0.02
Market Cap Chart
Since July 7, 2006, Oxurion NV's market cap has decreased from 100.46M to 1.24M, a decrease of -98.77%. That is a compound annual growth rate of -20.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 1.24M | 61.76% |
| Dec 31, 2024 | 766.13K | -73.79% |
| Dec 29, 2023 | 2.92M | -62.57% |
| Dec 30, 2022 | 7.81M | -88.99% |
| Dec 31, 2021 | 70.93M | -27.49% |
| Dec 31, 2020 | 97.83M | -13.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 36.57B |
| argenx SE | 33.89B |
| Financière de Tubize | 7.01B |
| Fagron NV | 1.51B |
| Ion Beam Applications | 337.74M |
| Nyxoah | 212.26M |
| Onward Medical | 184.61M |
| Hyloris Pharmaceuticals | 181.44M |